BioMérieux SA is a French healthcare company with a Risk Rating Score of 25.1, indicating a Medium Risk level. Specializing in in vitro diagnostics for detecting pathogens and contamination, BioMerieux operates in molecular biology, microbiology, immunoassays, and industrial applications. With a strong presence in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific regions, BioMerieux is a leading player in the healthcare industry. Headquarters in Marcy-l'Etoile, France.